申请人:Exelixis, Inc.
公开号:US08012956B2
公开(公告)日:2011-09-06
A compound according to Formula I or II:
wherein R1, R1b, R2, L1, and L2 and L2b are as defined in the specification, pharmaceutical compositions thereof, and methods of use thereof.
一种根据公式I或II的化合物:其中R1、R1b、R2、L1和L2和L2b如规范中所定义,其药物组成物和使用方法。